INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 41h ago
HOUSE PTR1h ago
SEC 13F1h ago
ROBINHOOD CHAIN1h ago
Institution
AM

ADAR1 Capital Management, LLC

10% OwnerCIK 0001940272

EDGAR filingsOpen in network
Disclosed transactions28
Buys / sells28 / 0
Max Insider Score47
Connections3with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
22
AM
ADAR1 Capital Management, LLC10% Owner
INMInMed Pharmaceuticals Inc.
Open-market purchase
BUY$5.28
4 sh
Oct 23, 2026Oct 27, 2026
traded Oct 23, 2026
+4dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    NextCure, Inc.10% Owner · Oct 27, 2026
  • Insider ofevidence
    TENAX THERAPEUTICS, INC.10% Owner · Aug 24, 2026
  • Insider ofevidence
    InMed Pharmaceuticals Inc.10% Owner · May 21, 2026
25
AM
ADAR1 Capital Management, LLC10% Owner
NXTCNextCure, Inc.
Open-market purchase
BUY
$8,418
1,672 sh
Oct 26, 2026
Oct 27, 2026
traded Oct 26, 2026
+1d
SEC FORM 4

Evidence

29
AM
ADAR1 Capital Management, LLC10% Owner
NXTCNextCure, Inc.
Open-market purchase
BUY$27K
5,626 sh
Oct 23, 2026Oct 27, 2026
traded Oct 23, 2026
+4dSEC FORM 4

Evidence

25
AM
ADAR1 Capital Management, LLC10% Owner
NXTCNextCure, Inc.
Open-market purchase
BUY$18K
3,553 sh
Oct 27, 2026Oct 27, 2026
traded Oct 27, 2026
+0dSEC FORM 4

Evidence

32
AM
ADAR1 Capital Management, LLC10% Owner
TENXTENAX THERAPEUTICS, INC.
Open-market purchase
BUY$507K
336.5K sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC FORM 4

Evidence

28
AM
ADAR1 Capital Management, LLC10% Owner
TENXTENAX THERAPEUTICS, INC.
Open-market purchase
BUY$551K
332.0K sh
Oct 21, 2026Oct 21, 2026
traded Oct 21, 2026
+0dSEC FORM 4

Evidence

28
AM
ADAR1 Capital Management, LLC10% Owner
TENXTENAX THERAPEUTICS, INC.
Open-market purchase
BUY$406K
254.3K sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC FORM 4

Evidence

22
AM
ADAR1 Capital Management, LLC10% Owner
INMInMed Pharmaceuticals Inc.
Open-market purchase
BUY$1,434
1,086 sh
Oct 19, 2026Oct 20, 2026
traded Oct 19, 2026
+1dSEC FORM 4

Evidence

22
AM
ADAR1 Capital Management, LLC10% Owner
INMInMed Pharmaceuticals Inc.
Open-market purchase
BUY$1.32
1 sh
Oct 16, 2026Oct 20, 2026
traded Oct 16, 2026
+4dSEC FORM 4

Evidence

22
AM
ADAR1 Capital Management, LLC10% Owner
INMInMed Pharmaceuticals Inc.
Open-market purchase
BUY$1,301
984 sh
Oct 15, 2026Oct 15, 2026
traded Oct 15, 2026
+0dSEC FORM 4

Evidence

22
AM
ADAR1 Capital Management, LLC10% Owner
INMInMed Pharmaceuticals Inc.
Open-market purchase
BUY$11K
8,021 sh
Oct 14, 2026Oct 15, 2026
traded Oct 14, 2026
+1dSEC FORM 4

Evidence

22
AM
ADAR1 Capital Management, LLC10% Owner
INMInMed Pharmaceuticals Inc.
Open-market purchase
BUY$750
564 sh
Oct 13, 2026Oct 15, 2026
traded Oct 13, 2026
+2dSEC FORM 4

Evidence

22
AM
ADAR1 Capital Management, LLC10% Owner
INMInMed Pharmaceuticals Inc.
Open-market purchase
BUY$4,051
3,046 sh
Oct 7, 2026Oct 8, 2026
traded Oct 7, 2026
+1dSEC FORM 4

Evidence

22
AM
ADAR1 Capital Management, LLC10% Owner
INMInMed Pharmaceuticals Inc.
Open-market purchase
BUY$2,997
2,256 sh
Oct 8, 2026Oct 8, 2026
traded Oct 8, 2026
+0dSEC FORM 4

Evidence

22
AM
ADAR1 Capital Management, LLC10% Owner
INMInMed Pharmaceuticals Inc.
Open-market purchase
BUY$7,436
5,601 sh
Oct 6, 2026Oct 8, 2026
traded Oct 6, 2026
+2dSEC FORM 4

Evidence

25
AM
ADAR1 Capital Management, LLC10% Owner
INMInMed Pharmaceuticals Inc.
Open-market purchase
BUY$11K
8,340 sh
Sep 16, 2026Sep 16, 2026
traded Sep 16, 2026
+0dSEC FORM 4

Evidence

32
AM
ADAR1 Capital Management, LLC10% Owner
INMInMed Pharmaceuticals Inc.
Open-market purchase
BUY$70K
54.3K sh
Sep 15, 2026Sep 16, 2026
traded Sep 15, 2026
+1dSEC FORM 4

Evidence

25
AM
ADAR1 Capital Management, LLC10% Owner
INMInMed Pharmaceuticals Inc.
Open-market purchase
BUY$37K
28.5K sh
Sep 14, 2026Sep 16, 2026
traded Sep 14, 2026
+2dSEC FORM 4

Evidence

46
AM
ADAR1 Capital Management, LLC10% Owner
TENXTENAX THERAPEUTICS, INC.
Open-market purchase
BUY$1.60M
900.0K sh
Sep 3, 2026Sep 8, 2026
traded Sep 3, 2026
+5dSEC FORM 4

Evidence

36
AM
ADAR1 Capital Management, LLC10% Owner
TENXTENAX THERAPEUTICS, INC.
Open-market purchase
BUY$322K
179.1K sh
Sep 1, 2026Sep 2, 2026
traded Sep 1, 2026
+1dSEC FORM 4

Evidence

36
AM
ADAR1 Capital Management, LLC10% Owner
TENXTENAX THERAPEUTICS, INC.
Open-market purchase
BUY$338K
187.7K sh
Sep 2, 2026Sep 2, 2026
traded Sep 2, 2026
+0dSEC FORM 4

Evidence

40
AM
ADAR1 Capital Management, LLC10% Owner
TENXTENAX THERAPEUTICS, INC.
Open-market purchase
BUY$723K
403.6K sh
Aug 31, 2026Sep 2, 2026
traded Aug 31, 2026
+2dSEC FORM 4

Evidence

39
AM
ADAR1 Capital Management, LLC10% Owner
TENXTENAX THERAPEUTICS, INC.
Open-market purchase
BUY$360K
202.1K sh
Aug 20, 2026Aug 24, 2026
traded Aug 20, 2026
+4dSEC FORM 4

Evidence

38
AM
ADAR1 Capital Management, LLC10% Owner
TENXTENAX THERAPEUTICS, INC.
Open-market purchase
BUY$1.27M
716.4K sh
Aug 21, 2026Aug 24, 2026
traded Aug 21, 2026
+3dSEC FORM 4

Evidence

28
AM
ADAR1 Capital Management, LLC10% Owner
TENXTENAX THERAPEUTICS, INC.
Open-market purchase
BUY$188K
107.4K sh
Aug 24, 2026Aug 24, 2026
traded Aug 24, 2026
+0dSEC FORM 4

Evidence

47
AM
ADAR1 Capital Management, LLC10% Owner
INMInMed Pharmaceuticals Inc.
Open-market purchase
BUY$312K
200.0K sh
May 19, 2026May 21, 2026
traded May 19, 2026
+2dSEC FORM 4

Evidence

40
AM
ADAR1 Capital Management, LLC10% Owner
INMInMed Pharmaceuticals Inc.
Open-market purchase
BUY$110K
68.6K sh
May 19, 2026May 21, 2026
traded May 19, 2026
+2dSEC FORM 4

Evidence

43
AM
ADAR1 Capital Management, LLC10% Owner
INMInMed Pharmaceuticals Inc.
Open-market purchase
BUY$300K
200.0K sh
May 19, 2026May 21, 2026
traded May 19, 2026
+2dSEC FORM 4

Evidence